Press release
Investigation announced for Long-Term Investors in Fulgent Genetics, Inc. (NASDAQ: FLGT)
An investigation on behalf of current long term investors in Fulgent Genetics, Inc. (NASDAQ: FLGT) shares.
Investors who are current long term investors in Fulgent Genetics, Inc. (NASDAQ: FLGT) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm for current long term investors in NASDAQ: FLGT stocks follows a lawsuit filed against Fulgent Genetics, Inc. over alleged securities laws violations. The investigation on behalf of current long term investors in Fulgent Genetics, Inc. (NASDAQ: FLGT stocks, concerns whether certain Fulgent Genetics, Inc. directors are liable in connection with the allegations made in that lawsuit.
According to that complaint filed in the U.S. District Court for the Central District of California the plaintiff alleges that, the Defendants made false and/or misleading statements and/or failed to disclose that Fulgent Genetics, Inc had been conducting medically unnecessary laboratory testing, engaging in improper billing practices in relation to laboratory testing, and providing or receiving remuneration in violation of the Anti-Kickback Statute and Stark Law, that accordingly, Fulgent Genetics, Inc was likely to become subject to enhanced legal and regulatory scrutiny, that Fulgent's revenues, to the extent they were derived from the foregoing unlawful conduct, were unsustainable, that the foregoing, once revealed, was likely to subject the Company to significant financial and/or reputational harm, and that as a result, the Company's public statements were materially false and misleading at all relevant times.
Those who purchased shares of Fulgent Genetics, Inc. (NASDAQ: FLGT) have certain options and should contact the Shareholders Foundation.
Contact:
Michael Daniels
Shareholders Foundation, Inc.
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108
Tel: +1-(858)-779-1554
E-Mail: mail@shareholdersfoundation.com
About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, and an investor advocacy group, which does research related to shareholder issues and informs investors of securities lawsuits, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Investigation announced for Long-Term Investors in Fulgent Genetics, Inc. (NASDAQ: FLGT) here
News-ID: 2905449 • Views: …
More Releases from Shareholders Foundation
SES AI Corporation (NYSE: SES) Investor Alert: Deadline in Lawsuit on June 26, 2 …
A deadline is coming up on June 26, 2026 in the lawsuit filed for certain investors of SES AI Corporation (NYSE: SES) over alleged securities laws violations by SES AI Corporation.
Investors who purchased shares of SES AI Corporation (NYSE: SES) have certain options and there are strict and short deadlines running. Deadline: June 26, 2026. SES AI Corporation (NYSE: SES) stockholders should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call…
Medpace Holdings, Inc. (NASDAQ: MEDP) Investor Alert: Deadline in Lawsuit on Jun …
A deadline is coming up on June 8, 2026 in the lawsuit filed for certain investors of Medpace Holdings, Inc. (NASDAQ: MEDP) over alleged securities laws violations by Medpace Holdings, Inc. (NASDAQ: MEDP).
Investors who purchased shares of Medpace Holdings, Inc. (NASDAQ: MEDP) have certain options and there are strict and short deadlines running. Deadline: June 8, 2026. Medpace Holdings, Inc. (NASDAQ: MEDP) stockholders should contact the Shareholders Foundation at mail@shareholdersfoundation.com…
Lawsuit filed for Investors who lost money with shares of Enphase Energy, Inc. ( …
An investor, who purchased shares of Enphase Energy, Inc. (NASDAQ: ENPH), filed a lawsuit over alleged violations of Federal Securities Laws by Enphase Energy, Inc. in connection with certain allegedly false and misleading statements.
Investors who purchased shares of Enphase Energy, Inc. (NASDAQ: ENPH) have certain options and for certain investors are short and strict deadlines running. Deadline: April 20, 2026. NASDAQ: ENPH investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com…
Investigation announced for Long-Term Investors in shares of Fiserv, Inc. (NYSE: …
An investigation was announced for current long-term investors in shares of Fiserv, Inc. (NYSE: FI) concerning potential breaches of fiduciary duties by certain directors and officers of Fiserv, Inc.
Investors who are current long term investors in Fiserv, Inc. (NYSE: FI) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm for current long term investors in…
More Releases for Fulgent
Newborn and Prenatal Genetic Testing Market Booming with Rapid Growth Through 20 …
Coherent Market Insights has released a report titled "Newborn and Prenatal Genetic Testing Market: Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2026-2033", which includes market percentage records and a thorough enterprise analysis. This report looks at the market's competition, geographic distribution, and growth potential. This comprehensive report encompasses industry performance, critical success factors, risk assessment, manufacturing prerequisites, project expenses, economic analysis, anticipated return on investment (ROI), and profit margins.
➤…
Prenatal Genetic Testing Market Set for Dynamic Growth with Key Players PerkinEl …
Coherent Market Insights has released a report titled "Prenatal Genetic Testing Market: Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2026-2033", which includes market percentage records and a thorough enterprise analysis. This report looks at the market's competition, geographic distribution, and growth potential. This comprehensive report encompasses industry performance, critical success factors, risk assessment, manufacturing prerequisites, project expenses, economic analysis, anticipated return on investment (ROI), and profit margins.
➤ Get Sample…
U.S. Genetic Testing Is Booming So Rapidly Growth by 2032 | Fulgent Genetics, My …
The qualitative latest Research report (2025-2032) on the U.S. Genetic Testing Market 2025-2032 by Coherent Market Insights Provides a deep dive into key market trends, drivers, challenges, and the competitive landscape. It analyzes market size, revenue, production, and CAGR using validated methodologies to ensure precision. The report highlights tech innovation, pricing trends, consumer behavior, and investment potential - empowering businesses to make informed, strategic moves.
➤ Request a Sample Copy: https://www.coherentmarketresearch.com/samplepages/140166
Focused…
Bardet-Biedl Syndrome Diagnostics Market Size, Share, Growth Insights and Report …
DataM Intelligence has published a new research report on "Bardet-Biedl Syndrome Diagnostics Market Size 2024". The report explores comprehensive and insightful Information about various key factors like Segmentation, CAGR, business revenue competitive positioning of key companies, investigating elements such as product offerings, pricing strategies, financial performance, product portfolios, growth initiatives, and geographical reach. . The purpose of this report is to provide a telescopic view of the current market size…
Cancer Gene Testing Service Market is Booming Worldwide with Latest Rising Trend …
The Latest research study released by HTF MI "Cancer Gene Testing Service - Global and China Top Players Market with 120+ pages of analysis on business Strategy taken up by key and emerging industry players and delivers know-how of the current market development, landscape, technologies, drivers, opportunities, market viewpoint, and status. Understanding the segments helps in identifying the importance of different factors that aid market growth. Some of the Major…
Deadline on Nov. 21st coming up in Lawsuit for Investors in Fulgent Genetics, In …
A deadline is coming up on November 21, 2022 in the lawsuit filed for certain investors of Fulgent Genetics, Inc. (NASDAQ: FLGT).
Investors who purchased shares of Fulgent Genetics, Inc. (NASDAQ: FLGT) have certain options and there are strict and short deadlines running. Deadline: November 21, 2022. NASDAQ: FLGT stockholders should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
According to the complaint filed in the U.S. District…
